VERACYTE, INC. Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount
VERACYTE, INC. (VCYT) reported Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount of $3.32 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount · last filed 2023-03-01
- VERACYTE, INC. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2020-12-31 was $1.00M.
- VERACYTE, INC. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2022 was $3.32M.
- VERACYTE, INC. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- VERACYTE, INC. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2020 was $1.00M.
- VERACYTE, INC. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2019 was $0.00.
| Period end | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 3 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 12 month |
|---|---|---|
| 2022-12-31 | $3.32M 10-K · filed 2023-03-01 | |
| 2021-12-31 | $0.00 10-K · filed 2023-03-01 | |
| 2020-12-31 | $1.00M 10-K · filed 2023-03-01 | $1.00M 10-K · filed 2023-03-01 |
| 2019-12-31 | $0.00 10-K · filed 2022-02-28 | |
| 2018-12-31 | $0.00 10-K · filed 2021-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |